Article
A null-mutation in the Znt7 gene accelerates prostate tumor formation in a transgenic adenocarcinoma mouse prostate model.
Cancer letters - 1 Sept 2011
Tepaamorndech Surapun, Huang Liping, Kirschke Catherine P
Abstract excerpt
Decrease of cellular zinc in the epithelium of the prostate has been implicated in the development of prostate cancer. To investigate whether ZnT7, a zinc transporter involved in intracellular zinc accumulation, played a role in prostate cancer development, we generated and characterized a transgenic adenocarcinoma mouse prostate (TRAMP) model with a Znt7-null genetic background. TRAMP mice (TRAMP/Znt7(-/-) and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
